Controlled study of fluconazole in the prevention of fungal infections in neutropenic patients with haematological malignancies and bone marrow transplant recipients

European Journal of Clinical Microbiology & Infectious Diseases

Volumn 13, Issue 1, 1994, Pages 3-11

  Ellis, M E ^a   Clink, H ^a   Ernst, P ^a   Halim, M A ^a   Padmos, A ^a   Spence, D ^a   Kalin, M ^b   Hussain Qadri, S M ^a   Burnie, J ^c   Greer, W ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CETYLPYRIDINIUM SALT; CLOTRIMAZOLE; DIPHENHYDRAMINE; FLUCONAZOLE; NYSTATIN;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL TRACT; HUMAN; LEUKEMIA; LUNG ASPERGILLOSIS; MALE; MORTALITY; MUSCLE CRAMP; MYCOSIS; NAUSEA; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; TOPICAL DRUG ADMINISTRATION; UROGENITAL SYSTEM;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CLOTRIMAZOLE; FEMALE; FLUCONAZOLE; HUMANS; LEUKEMIA; LYMPHOMA; MALE; MIDDLE AGED; MYCOSES; NEUTROPENIA; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0027972366     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/BF02026116     Document Type: Article

References (20)

1. Infection in cancer patients: a continuing association
2. Aspergillosis. The spectrum of the disease in 98 patients
3. Fungal infections in patients with acute leukemia
4. Retrospective review of amphotericin B use in a tertiary-care medical center
5. Candida infections in patients with acute leukemia: ineffectiveness of nystatin prophylaxis and relationship between oropharyngeal and systemic candidiasis
6. Oral ketoconazole and amphotericin B for the prevention of yeast colonization in patients with acute leukaemia
7. Prophylaxis of oral candidiasis with clotrimazole troches
8. Prevention of mycoses in immunocompromised patients
9. Hann IM, Corringham R, Keaney M, Noone P, Fox J, Szawatkowski M, Prentice HG, Blacklock HA, Shannon M, Gascoigne E, Boesen E, Hoffbrand AV: Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients. Lancet 1982, 826–829.
10. Fluconazole: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses
11. Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response
12. Favorable outcome of invasive aspergillosis in patients with acute leukemia
13. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation
14. Pharmacokinetic evaluation of UK 49858, a metabolically stable triazole antifungal in animals and humans
15. Efficacy of Fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice
16. The role of fluconazole in the early treatment and prophylaxis of experimental invasive aspergillosis
17. Fluconazole and other azoles: translation of in vitro activity to in vivo and clinical efficacy
18. Candida infections in bone marrow transplant recipients
19. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole